Symbol: |
APOL5
|
Description: |
apolipoprotein L, 5 [Source:HGNC Symbol;Acc:14869]
|
Location: |
Chr22:36113919-36125530[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:56
Gene |
Compound |
Gen_sig |
Exp_pattern |
APOL5 |
Musennin |
0.048 |
Down |
APOL5 |
Lobinaline, monohydrochloride |
0.034 |
Up |
APOL5 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.016 |
Up |
APOL5 |
Ethanesulfonic acid, compd. with 5-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]-o-toluenesulfonyl fluoride (1:1) |
0.005 |
Up |
APOL5 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.005 |
Up |
APOL5 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.035 |
Up |
APOL5 |
NSC 15795 |
0.043 |
Up |
APOL5 |
Viridomycin |
0.032 |
Up |
APOL5 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.032 |
Up |
APOL5 |
2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- |
0.024 |
Up |
APOL5 |
Piperidine, 2,6-diphenyl-1-methyl-4-[(phenylmethoxy)imino]-, cis- |
0.004 |
Up |
APOL5 |
NSC 401101 |
0.036 |
Up |
APOL5 |
NSC 408470 |
0.048 |
Up |
APOL5 |
NSC 56614 |
0.042 |
Up |
APOL5 |
NSC 58903 |
0.029 |
Up |
Expression pattern: Sensitivity / Resistance
Total:4 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:3
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:20
Total:2 Current:1
[First] [Prev]  Next Last 
|